Literature DB >> 17924606

Learning how and when to employ uricase as bridge therapy in refractory gout.

Robert Terkeltaub.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17924606

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  6 in total

Review 1.  The challenges of gout management in the elderly.

Authors:  Lisa K Stamp; Sarah Jordan
Journal:  Drugs Aging       Date:  2011-08-01       Impact factor: 3.923

2.  Dual energy computed tomography for quantification of tissue urate deposits in tophaceous gout: help from modern physics in the management of an ancient disease.

Authors:  A Kirstin Bacani; Cynthia H McCollough; Katrina N Glazebrook; Jeffrey R Bond; Clement J Michet; Jeffrey Milks; Nisha J Manek
Journal:  Rheumatol Int       Date:  2009-12-17       Impact factor: 2.631

Review 3.  Gout. Novel therapies for treatment of gout and hyperuricemia.

Authors:  Robert Terkeltaub
Journal:  Arthritis Res Ther       Date:  2009-07-23       Impact factor: 5.156

4.  New advances in the treatment of gout: review of pegloticase.

Authors:  Mattheus K Reinders; Tim L Th A Jansen
Journal:  Ther Clin Risk Manag       Date:  2010-10-27       Impact factor: 2.423

Review 5.  Update on gout: new therapeutic strategies and options.

Authors:  Robert Terkeltaub
Journal:  Nat Rev Rheumatol       Date:  2010-01       Impact factor: 20.543

6.  Plasmodium falciparum-derived uric acid precipitates induce maturation of dendritic cells.

Authors:  Diana L van de Hoef; Isabelle Coppens; Thomas Holowka; Choukri Ben Mamoun; OraLee Branch; Ana Rodriguez
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.